Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurobiology of opioid dependence in creating addiction vulnerability
Christopher J. Evans, Catherine M. Cahill
F1000Research (2016) Vol. 5, pp. 1748-1748
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement
George F. Koob
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 44-53
Closed Access | Times Cited: 396
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
George F. Koob
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 163-201
Open Access | Times Cited: 233
Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder
Marianne L. Seney, Sam-Moon Kim, Jill R. Glausier, et al.
Biological Psychiatry (2021) Vol. 90, Iss. 8, pp. 550-562
Open Access | Times Cited: 113
The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence
Kevin Lee, Helen E. Vuong, David J. Nusbaum, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2606-2614
Open Access | Times Cited: 158
The Mechanisms Involved in Morphine Addiction: An Overview
Joanna Listos, Małgorzata Łupina, Sylwia Talarek, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4302-4302
Open Access | Times Cited: 144
Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework
Ju Nyeong Park, Saba Rouhani, Leo Beletsky, et al.
Milbank Quarterly (2020) Vol. 98, Iss. 3, pp. 700-746
Open Access | Times Cited: 125
Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation
Catherine M. Cahill, Wendy Walwyn, Anna M.W. Taylor, et al.
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 11, pp. 963-976
Open Access | Times Cited: 109
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain
Shiwei Liu, Sarah R. Pickens, Nicole E. Burma, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 21, pp. 4162-4178
Open Access | Times Cited: 100
Orchestrating Opiate-Associated Memories in Thalamic Circuits
Piper C. Keyes, Eliza L. Adams, Zijun Chen, et al.
Neuron (2020) Vol. 107, Iss. 6, pp. 1113-1123.e4
Open Access | Times Cited: 95
American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy
David A. Edwards, Traci L. Hedrick, Jennifer Jayaram, et al.
Anesthesia & Analgesia (2019) Vol. 129, Iss. 2, pp. 553-566
Open Access | Times Cited: 87
Oxycodone in the Opioid Epidemic: High ‘Liking’, ‘Wanting’, and Abuse Liability
Cherkaouia Kibaly, Jacob A. Alderete, Steven Liu, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 5, pp. 899-926
Open Access | Times Cited: 75
Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine
Rebecca S. Hofford, Nicholas L. Mervosh, Tanner J. Euston, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2062-2072
Open Access | Times Cited: 57
Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders
George F. Koob
Current topics in behavioral neurosciences (2022), pp. 147-165
Closed Access | Times Cited: 51
Molecular mechanisms of morphine tolerance and dependence; novel insights and future perspectives
Ismail Badshah, Maira Anwar, Babar Murtaza, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 6, pp. 1457-1485
Closed Access | Times Cited: 22
Negative affectivity drivers of impulsivity in opioid use disorder
Jasmin Vassileva, Elena Psederska, James M. Bjork
Nature Reviews Psychology (2025)
Closed Access | Times Cited: 1
Neuroinflammation—a co-occurring phenomenon linking chronic pain and opioid dependence
Catherine M. Cahill, Anna M.W. Taylor
Current Opinion in Behavioral Sciences (2017) Vol. 13, pp. 171-177
Open Access | Times Cited: 72
Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
Camila L. Arnaudo, Barbara Andraka‐Christou, Kacy Allgood
Current Addiction Reports (2017) Vol. 4, Iss. 1, pp. 1-13
Open Access | Times Cited: 71
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
Jenny L. Wilkerson, Sudeshna Ghosh, Mohammed Ahmed Mustafa, et al.
Neuropharmacology (2016) Vol. 114, pp. 156-167
Open Access | Times Cited: 70
The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models
Lola Welsch, Julie Bailly, Emmanuel Darcq, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 54-63
Open Access | Times Cited: 68
Non-nociceptive roles of opioids in the CNS: opioids’ effects on neurogenesis, learning, memory and affect
Cherkaouia Kibaly, Chi Xu, Catherine M. Cahill, et al.
Nature reviews. Neuroscience (2018) Vol. 20, Iss. 1, pp. 5-18
Open Access | Times Cited: 67
Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system
Emilia M. Lefevre, Marc T. Pisansky, Carlee Toddes, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 11, pp. 1781-1792
Open Access | Times Cited: 64
Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis
Sean O’Sullivan, Evangelia Malahias, James K. Park, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 57
Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction
Caroline B. Pantazis, Luis Antonio Pérez González, Brendan J. Tunstall, et al.
Science Advances (2021) Vol. 7, Iss. 15
Open Access | Times Cited: 49
Neurodevelopmental origins of substance use disorders: Evidence from animal models of early‐life adversity and addiction
S Levis, Tallie Z. Baram, Stephen V. Mahler
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2170-2195
Open Access | Times Cited: 48
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
Marjorie R. Levinstein, Meghan L. Carlton, Tommaso Di Ianni, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 12, pp. 1118-1126
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top